|
Characteristics
|
Patients
|
|---|
|
Age(y)
|
61 (53–68)
|
|
Gender
|
|
Male
|
383 (69.5%)
|
|
Female
|
168 (30.5%)
|
|
Smoking history
|
|
Y
|
355 (64.4%)
|
|
N
|
196 (35.6%)
|
|
Stage
|
|
I-II
|
354 (64.2%)
|
|
IIIA
|
197 (35.8%)
|
|
Pathological tumor
|
|
classification (pT)
|
|
pT1–2
|
475 (86.2%)
|
|
pT3–4
|
76 (13.8%)
|
|
Pathological lymph node
|
|
stage (pN)
|
|
pN0
|
298 (54.1%)
|
|
pN1–2
|
253 (45.9%)
|
|
Histological type
|
|
Squamous cell carcinoma
|
174 (31.6%)
|
|
Adenocarcinoma
|
329 (59.7%)
|
|
Large cell carcinoma
|
48 (8.7%)
|
|
Surgery type
|
|
Lobectomy
|
395 (71.7%)
|
|
Pneumonectomy
|
120 (21.8%)
|
|
Other
|
36 (6.5%)
|
|
Adjuvant chemotherapy
|
|
Y
|
299 (54.3%)
|
|
N
|
252 (45.7%)
|
|
GLU (mmol/L)
|
5.27 (4.78–5.88)
|
|
TC (mmol/L)
|
4.20 (3.63–4.89)
|
|
TG (mmol/L)
|
1.09 (0.80–1.72)
|
|
HDL-C (mmol/L)
|
1.17 (0.97–1.40)
|
|
LDL-C (mmol/L)
|
2.55 (2.08–3.08)
|
|
ApoA1(g/L)
|
1.15 (1.01–1.29)
|
|
Apo B(g/L)
|
0.85 (0.71–1.02)
|
|
Lpa (mg/L)
|
189 (90–408)
|
- Continuous variables were shown as median (first-third interquartile range [IQR])
- Categorical variables were shown as percentages
